| TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, ... Nucleic acids research 44 (8), e71-e71, 2016 | 3119 | 2016 |
| Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 3038 | 2015 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 2102 | 2016 |
| Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications TM Malta, CF de Souza, TS Sabedot, TC Silva, MS Mosella, SN Kalkanis, ... Neuro-oncology 20 (5), 608-620, 2018 | 284 | 2018 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 267 | 2022 |
| A global metagenomic map of urban microbiomes and antimicrobial resistance D Danko, D Bezdan, EE Afshin, S Ahsanuddin, C Bhattacharya, DJ Butler, ... Cell 184 (13), 3376-3393. e17, 2021 | 255 | 2021 |
| A distinct DNA methylation shift in a subset of glioma CpG island methylator phenotypes during tumor recurrence CF de Souza, TS Sabedot, TM Malta, L Stetson, O Morozova, A Sokolov, ... Cell reports 23 (2), 637-651, 2018 | 172 | 2018 |
| A serum-based DNA methylation assay provides accurate detection of glioma TS Sabedot, TM Malta, J Snyder, K Nelson, M Wells, AC DeCarvalho, ... Neuro-oncology 23 (9), 1494-1508, 2021 | 72 | 2021 |
| Predicting master transcription factors from pan-cancer expression data J Reddy, MAS Fonseca, RI Corona, R Nameki, F Segato Dezem, IA Klein, ... Science advances 7 (48), eabf6123, 2021 | 57 | 2021 |
| RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes R Mall, L Cerulo, L Garofano, V Frattini, K Kunji, H Bensmail, TS Sabedot, ... Nucleic acids research 46 (7), e39-e39, 2018 | 50 | 2018 |
| Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma CMS Tesileanu, MJ Van Den Bent, M Sanson, W Wick, AA Brandes, ... Neuro-oncology 23 (9), 1547-1559, 2021 | 42 | 2021 |
| Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas V Ruiz-Rodado, TM Malta, T Seki, A Lita, T Dowdy, O Celiku, ... Neuro-oncology 22 (4), 480-492, 2020 | 41 | 2020 |
| Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas E Kocakavuk, KC Johnson, TS Sabedot, HC Reinhardt, H Noushmehr, ... Neuro-oncology 25 (9), 1721-1723, 2023 | 22 | 2023 |
| SIRT1 regulates Mxd1 during malignant melanoma progression FM Meliso, D Micali, CT Silva, TS Sabedot, SG Coetzee, A Koch, ... Oncotarget 8 (70), 114540, 2017 | 21 | 2017 |
| The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen TM Malta, TS Sabedot, NS Morosini, I Datta, L Garofano, W Vallentgoed, ... Cancer research 84 (5), 741-756, 2024 | 20 | 2024 |
| Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas GA Herrgott, JM Snyder, R She, TM Malta, TS Sabedot, IY Lee, J Pawloski, ... Nature Communications 14 (1), 5669, 2023 | 17 | 2023 |
| Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors GA Herrgott, KP Asmaro, M Wells, TS Sabedot, TM Malta, MS Mosella, ... Neuro-oncology 24 (7), 1126-1139, 2022 | 14 | 2022 |
| EPCO-09. LONGITUDINAL ANALYSIS OF DIFFUSE GLIOMA REVEALS CELL STATE DYNAMICS AT RECURRENCE ASSOCIATED WITH CHANGES IN GENETICS AND THE MICROENVIRONMENT F Varn, K Johnson, T Wade, T Malta, T Sabedot, F Barthel, H Kim, ... Neuro-Oncology 23 (Supplement_6), vi3-vi3, 2021 | 14* | 2021 |
| DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features MS Mosella, TS Sabedot, TC Silva, TM Malta, FS Dezem, KP Asmaro, ... Neuro-oncology 23 (8), 1292-1303, 2021 | 12 | 2021 |
| Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers H Noushmehr, TS Sabedot, TM Malta, K Nelson, J Snyder, M Wells, ... BioRxiv, 601245, 2019 | 11 | 2019 |